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Abstract
Gene therapy has generated worldwide attention as a new medical technology. While non-viral
gene vectors are promising candidates as gene carriers, they have several issues such as
toxicity and low transfection efficiency. We have hypothesized that the generation of reactive
oxygen species (ROS) affects gene expression in polyplex supported gene delivery systems.
The effect of ROS on the gene expression of polyplex was evaluated using a nitroxide
radical-containing nanoparticle (RNP) as an ROS scavenger. When polyethyleneimine
(PEI)/pGL3 or PEI alone was added to the HeLa cells, ROS levels increased significantly. In
contrast, when (PEI)/pGL3 or PEI was added with RNP, the ROS levels were suppressed. The
luciferase expression was increased by the treatment with RNP in a dose-dependent manner
and the cellular uptake of pDNA was also increased. Inflammatory cytokines play an
important role in ROS generation in vivo. In particular, tumor necrosis factor (TNF)-α caused
intracellular ROS generation in HeLa cells and decreased gene expression. RNP treatment
suppressed ROS production even in the presence of TNF-α and increased gene expression.
This anti-inflammatory property of RNP suggests that it may be used as an effective adjuvant
for non-viral gene delivery systems.
Keywords: non-viral gene delivery system, anti-inflammation, reactive oxygen species,
nitroxide radical-containing nanoparticle, polyplex
1. Introduction
Recent developments in molecular targeted therapy have
markedly changed the concept of drug design. Drugs
have evolved from traditional low-molecular-weight synthetic
compounds to high-molecular-weight compounds such as
enzymes and antibodies. Gene therapy has generated consi-
derable worldwide attention as a forthcoming technology with
a high efficiency in targeting genetic diseases and cancers
[1, 2].
One of the most serious issues concerning effective
gene therapy is the in vivo delivery of genes. Viral
vectors have been studied and evaluated as effective gene
carriers. However, exogenous viral vectors can cause side
effects such as inflammation, antigenicity and carcinogenicity.
High safety and performance are thus required for novel
gene carriers [3–5]. Non-viral gene vectors are promising
candidates as gene carriers that lack the many adverse effects
of viral vectors. The polyion complex with a polycation
is a representative non-viral vector that electrostatically
interacts with DNA [6]. However, in contrast to viral vectors,
these synthetic vectors have several drawbacks such as
toxicity and low transfection efficiency. A representative
example is polyplex, a major gene carrier and a polyion
complex between negatively charged DNA and polycations,
such as polyethyleneimine (PEI), poly(L-lysine), chitosan
and cationic dendrimer. Polyplex is relatively stable against
enzymatic degradation owing to the compaction of the
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Figure 1. Schematic of RNP.
DNA molecule in the complex [7–12]. However, although
the high-molecular-weight polyamine in polyplex possesses
strong cationic charges, it shows significant cellular toxicity
because of electrostatic interactions with negatively charged
cell membranes. For instance, when PEI is mixed with
cultured leukemic monocyte macrophage cells, it induces
the generation of inflammatory cytokines such as tumor
necrosis factor-α (TNF-α) and interleukin-6 (IL-6) [13].
These cytokines in turn activate the key regulators of the
immune system, nuclear factor-κB (NF-κB) [14], followed
by an induction of downstream cytokines. This causes the
generation of reactive oxygen species (ROS), resulting in the
amplification of the inflammation reaction [15–17]. Yang et al
clearly demonstrated that the ROS generation was increased
with increasing in the molecular weight of PEI [16]. We
hypothesized that ROS generation and inflammation reaction
strongly correlate with the inefficient gene expression in the
case of the polyamine-based non-viral gene delivery system.
Nitroxide radical is known to catalytically react with
ROS owing to its redox characteristics. For example,
4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPOL),
which is a stable nitroxide radical, is a known ROS scavenger
that efficiently scavenges superoxide and hydroxyl radicals
in vitro [18]. The ROS scavenging property of the nitroxide
radical plays a role in suppressing the immunoresponse
and inflammation in vitro by inhibiting the activation of
NF-κB [19].
We have developed a novel nitroxide radical-containing
nanoparticle (RNP) that effectively scavenges ROS
because it contains 3000 to 5000 nitroxide radicals in
the core (figure 1) [20, 21]. The RNP was prepared
from self-assembling amphiphilic block copolymers
(MeO-PEG-b-PMS-TEMPO) composed of a hydrophilic
poly(ethylene glycol) (PEG) segment and a hydrophobic
poly(methylstyrene) (PMS) segment possessing TEMPO
moieties. This nanoparticle design makes it feasible for
in vivo use because of the prevention of rapid renal excretion
of low-molecular-weight TEMPOL and reduction under
cellular conditions. During the course of our study, RNP
decreased the acute toxicity caused by ROS [22, 23]. If the
ROS scavenging property of the nitroxide radical effectively
enhances gene expression in polyplex, the non-viral gene
therapy would become more feasible.
In this report, RNP was examined as an adjuvant for
in vitro gene expression. Branched PEI (25 kDa) was
employed as a complexing agent for the pGL3 gene. HeLa
cells were treated with PEI/pDNA with or without RNP,
and the ROS generation and transfection efficiency were
examined.
2. Materials and methods
2.1. Chemicals
PEI (Branched, 25 kDa) and methoxyl-poly(ethylene
glycol)-sulfanyl (MeO-PEG-SH) were purchased from
Aldrich (Milwaukee, WI, USA) and NOF Corporation
(Tokyo, Japan), respectively. Chloromethylstyrene (CMS)
was kindly provided by Seimi Chemical Co., Ltd. (Kanagawa,
Japan). 4-Amino-2,2,6,6-tetramethylpiperidinyl-1-oxyl
(4-amino-TEMPO) was purchased from Aldrich Chemical
Co, Inc, USA, and TNF-α was purchased from WAKO Pure
Chemical Industries, Ltd (Osaka, Japan).
2.2. Synthesis of RNP
RNP was prepared following the methods of Yoshitomi
et al [20]. An amphiphilic block copolymer possessing
a poly(ethylene glycol) (PEG) chain as a hydrophilic
segment and a polystyrene chain as a hydrophobic segment
with TEMPO repeating units was prepared using two-step
reactions. After the PEG-b-poly(chloromethylstyrene)
(PEG-b-PCMS) was prepared by the radical telomerization
reaction of CMS using MeO-PEG-SH as a telogen,
4-amino-TEMPO was immobilized as a side chain of the
PCMS segment by the amination reaction. RNP was prepared
from the synthesized polymer (MeO-PEG-b-PMS-TEMPO)
by the dialysis method.
2.3. Cell culture
Human cervical cancer cells (HeLa) were cultured in
Dulbecco’s Modified Eagle’s Medium (DMEM; Sigma,
St. Louis, MO) with 10% fetal bovine serum (FBS; Invitrogen,
Carlsbad, CA, USA) and 1% penicillin/streptomycin
(Invitrogen) at 37 ◦C under 5% CO2.
2.4. Plasmid DNA and pDNA/PEI complex
The plasmid pGL3-control pDNA coding for the firefly
luciferase gene (Promega, Madison, WI, USA) was amplified
in Escherichia coli. The plasmid was isolated and purified
using a QIAGEN HiSpeed Plasmid Maxi Kit (Qiagen, Hilden,
Germany). PEI/ pDNA complex was prepared by mixing
indicated amounts of plasmid DNA with PEI at N/P ratios
of 10 (N/P = molar ratio of PEI amino group to DNA
phosphate).
2.5. Transfection of HeLa cells
HeLa cells were seeded in a 24-well plate (1× 105 cells per
well). After 24 h, PEI/pDNA complex (DNA = 0.75µg per
2
Sci. Technol. Adv. Mater. 12 (2011) 065001 K Toh et al
well, N/P = 10), RNP (final polymer concentrations were
0.033, 0.33, 3.3 and 33µM), and TNF-α (final concentrations
were 0.06, 0.6 and 6 nM) were added to each well. The RNP
concentration which is low enough not to induce cytotoxicity
was used according to our previous paper [20]. After a 24 h
incubation, the transfection medium was changed to fresh
DMEM with 10% FBS, and the cells were further incubated
for 24 h. After the incubation, the cells were washed with
phosphate-buffered saline (PBS) twice. The cells were lysed
in reporter lysis buffer (Promega), and luciferase activities
were measured using the Luciferase Assay Kit (Promega).
The results were expressed as light units per milligram of cell
protein determined using the BCA Protein Assay Kit (Pierce,
Rockford, IL, USA).
2.6. Cellular uptake of pDNA
Fluorescein isothiocyanate (FITC)-labeled pDNA was
prepared using a Label IT Nucleic Acid Labeling Kit (Mirus
Bio LLC, Madison, WI, USA). HeLa cells were seeded
at a density of 1× 105 cells per well in a 24-well dish
and kept overnight at 37 ◦C in 5% CO2 atmosphere. The
PEI/pDNA polyplex micelles (N/P = 10) were added at a
pDNA concentration of 0.75µg/well and incubated at 37 ◦C
in 5% CO2 atmosphere in the presence or absence of RNP
(33µM) for 18 h. The cells were washed with PBS twice.
FITC fluorescence intensities of cells were detected using a
flow cytometer (Guava EasyCyte Mini System; Millipore).
2.7. Intracellular ROS measurement
HeLa cells were seeded in a 24-well plate (1× 105 cells/well).
After 24 h, RNP (final concentration was 33µM),
PEI/pDNA complex (DNA = 0.75µg/well, N/P = 10),
PEI (same concentration with PEI/pDNA), and TNF-α
(final concentrations were 0.06, 0.6 and 6 nM) were
added to each well. After 48 h incubation, the cells were
washed once in 1 ml of PBS. One milliliter of a 10µM
solution of 2′,7′-dichlorodihydrofluorescein diacetate
(DCFH-DA; WAKO) for hydroxyl radical determination,
or dehydroethidine (HE; WAKO) for superoxide anion
determination was added to each well, followed by incubation
for 15 min at 37 ◦C in the dark. The dyes were then
removed and the cells were washed once with 1 ml of
PBS. The cells were harvested by scraping and placed in
1.5 ml tubes containing 500µl of PBS. The production of
intracellular ROS was measured by flow cytometry. The mean
fluorescence intensity of 5000 cells was quantified using the
Guava EasyCyte Mini System.
3. Results and discussion
3.1. ROS scavenging effect of RNP on PEI/pDNA gene
delivery system
The ROS scavenging effect of RNP on gene expression was
measured by adding RNP into a cell culture model. RNP
and polyplex were added simultaneously to the culture dish
because the ROS generation has been reported to occur
Figure 2. Effects of RNP on ROS levels in HeLa cells. ROS levels
in HeLa cells were measured by flow cytometry. Graphs indicate
relative fluorescence intensities (%) derived from (a) DCF (hydroxyl
radical) and (b) HE (superoxide anion) of HeLa cells treated with
polyplex (PEI/pDNA) or polymer (PEI) compared with untreated
control cells. pGL3 (0.75µg per well) was transfected as a
PEI/pDNA complex (N/P = 10). PEI was added at the same
concentration as the PEI of polyplex. The experiments were
repeated twice (n = 3, ∗P < 0.01).
immediately [13]. We investigated whether RNP suppressed
ROS levels during the transfection experiment, and used two
fluorescent dyes for detecting ROS: DCFH-DA for hydroxyl
radicals and HE for superoxide anion. As shown in figure 2(a),
the addition of PEI alone or PEI/pDNA polyplex significantly
increased the concentration of the hydroxyl radical due to
the stimulation of HeLa cells by cationic polyamines. When
RNP was added to the culture medium, the ROS levels
decreased significantly, indicating that the nitroxide radical
in RNP worked as an effective hydroxyl radical scavenger,
as anticipated. A similar tendency was observed in the case
of superoxide radicals (figure 2(b)), although the difference
in the concentration of superoxide radicals, with and without
RNP, was unremarkable.
Before the effect of RNP on the transfection efficiency
was evaluated, the interaction between RNP and the
PEI/pDNA polyplex was investigated by electron spin
resonance (ESR). We have already confirmed that the ESR
3
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Figure 3. Luciferase gene expression in Hela cells transfected with
PEI/pDNA with RNP. PEI/pDNA complex (N/P = 10) was
transfected into HeLa cells. The luciferase expression ratio was
normalized to the expression level at RNP (0 mM)= 1. The
experiments were repeated 4 times (n = 5, ∗P < 0.01).
spectra of RNP markedly change from a broad to sharp triplet
due to the disintegration of RNP [20]. If RNP interacts with
the PEI/pDNA polyplex, a change in the ESR spectra of
RNP must be observed owing to the morphology change in
RNP. When RNP was mixed with the PEI/DNA polyplex,
no change in the ESR spectra of RNP was detected, namely,
a broad signal was observed regardless of the RNP/polyplex
ratio (data not shown); this result indicates no interaction
between RNP and the PEI/pDNA polyplex under the present
conditions. The effect of RNP on the transfection efficiency
of the PEI/pDNA polyplex was then evaluated in vitro
using HeLa cells. As shown in figure 3, the gene expression
increased significantly with increasing amount of RNP
(> 3.3µM). At 33.3µM of RNP concentration, the
expression of PEI/pDNA was 2.5 times higher than that
without RNP addition. No significant change in protein
content was found regardless of the RNP concentrations
indicating no significant difference in the cell viability for
these experiments.
To elucidate the mechanism of the increased expression
of the PEI/pDNA polyplex in the presence of RNP, the
cellular uptake of FITC-labeled PEI/pDNA to HeLa cells
was evaluated with and without RNP. The uptake of the
FITC-labeled PEI/pDNA was investigated by flow cytometry.
When transfection of the PEI/pDNA polyplex was carried out
in the presence of RNP, the uptake of pDNA almost doubled,
as shown in figure 4. Although other steps during the gene
delivery and expression might be improved by RNP, RNP
definitely enhanced the cellular uptake of plasmid DNA.
3.2. Effect of inflammatory cytokine
Since polyamines are positively charged, they strongly
interact with the anionic cellular membrane, enhancing the
levels of inflammatory cytokines such as TNF-α and IL-6
from macrophages and/or neutrophils. These cytokines can
stimulate transcriptional factors such as NF-κB and cause
Figure 4. Uptake of FITC-labeled pDNA into HeLa cells. The
figure shows relative fluorescence intensities for HeLa cells treated
with FITC-labeled PEI/pDNA with or without RNP (33µM). The
experiments were repeated twice (n = 3, ∗P < 0.01).
Figure 5. Effects of RNP on ROS levels in HeLa cells treated with
TNF-α. ROS levels in HeLa cells were measured by flow cytometry.
The figure shows relative fluorescence intensities (%) from (a) DCF
(hydroxyl radical) and (b) HE (superoxide anion) of HeLa cells
treated with TNF-α (0, 0.06, 0.6 and 6 nM) with or without RNP
(33µM) compared with untreated control cells. The experiments
were repeated twice (n = 3, ∗P < 0.01, ∗∗P < 0.05).
inflammation. TNF-α is also reported to induce mitochondrial
ROS generation [15], which stimulates NF-κB. Thus, both
cytokines and ROS amplify inflammation. ROS generation
strongly correlates with the cellular uptake of the PEI/pDNA
polyplex as shown in figure 4, and we hypothesized that
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Figure 6. Relative luciferase gene expression in HeLa cells treated
with TNF-α. HeLa cells treated with TNF-α (0, 0.06, 0.6 and 6 nM)
and RNP [(−): 0µM; (+): 33µM]. pGL3 (0.75µg per well) was
transfected as PEI/pDNA complex (N/P = 10). The luciferase
expression ratio was normalized to that of untreated cells
[TNF-α = 0, and RNP(−)= 1]. The experiments were repeated
4 times (n = 5, ∗P < 0.01).
increased inflammation plays an important role in the gene
expression efficiency. Therefore, in vitro gene expression
efficiency of the polyplex was examined in the presence of
TNF-α, and the ROS scavenging effect of RNP on gene
expression was also evaluated.
The treatment with TNF-α was confirmed to increase the
production of both types of ROS, whereas the addition of RNP
effectively suppressed intracellular ROS production as shown
in figures 5(a) and (b). Accordingly, it was reconfirmed that
RNP effectively scavenged ROS produced by inflammatory
cytokine. Figure 6 shows the luciferase gene expression
in HeLa cells stimulated with TNF-α. The level of gene
expression decreased with increasing TNF-α concentration.
By the addition of RNP, however, gene expression was
restored even under the high concentration of TNF-α.
Because the total protein amounts in the cells remained
unchanged regardless of the TNF-α concentration, there was
no significant effect of TNF-α on cell viability. Accordingly,
the gene expression was restored by the addition of RNP due
to the ROS-scavenging effect of RNP. From these results, we
conclude that ROS scavenging is a rational and valid strategy
to improve the expression of genes in a gene delivery system.
4. Conclusions
We have investigated the gene expression efficiency of
polyplex in the presence and absence of RNP, which is a
novel ROS scavenger that we developed. Suppression of ROS
generation reduced the inflammation caused by polyamines
and increased the cellular uptake of polyplex; this resulted in
increased gene expression efficiency. Although the detailed
mechanism of action is now being investigated, we consider
that the suppression of ROS and inflammation can provide a
new strategy to the field of gene delivery.
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